Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats

Clinical and Experimental Hypertension

Volumn A11, Issue 7, 1989, Pages 1325-1350

  Linz, Wolfgang ^a,c   Schölkens, Bernward A ^a   Ganten, Detlev ^b  

^a SANOFI   (France)

^b German Institute for High Blood Pressure Research   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiotensin II; Aortic banding; Converting enzyme; Converting enzyme inhibitor; Dihydralazine; Nifedipine; Prevention and regression of cardiac hypertrophy; Ramipril

Indexed keywords

ANGIOTENSIN; DIHYDRALAZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE; RAMIPRIL;

ANIMAL EXPERIMENT; BLOOD PRESSURE; HEART HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; ANTIHYPERTENSIVE AGENTS; BICYCLO COMPOUNDS; CARDIOMEGALY; COMPARATIVE STUDY; DIHYDRALAZINE; HYPERTENSION; MALE; NIFEDIPINE; RAMIPRIL; RATS; RATS, INBRED STRAINS;

EID: 0024448370     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641968909038172     Document Type: Article

References (49)

1. Regression of left ventricular hypertrophy during treatment with antihypertensive agents
2. The effect of antihypertensive treatment with methyl-dopa on left ventricular mass
3. Echocardio-graphic studies of left ventricular anatomy and function before and after treatment of essential hypertension
4. Assessment of left-ventricular mass and its response to antihypertensive treatment
5. The heart in hypertension
6. The heart in hypertension
7. Cardiac hypertrophy in spontaneous hypertensive rats
8. Is arterial pressure the sole factor responsible for hypertensive cardic hypertrophy?
9. Reversal of cardiac hypertrophy in renal hypertensive rats: medical vs. surgical therapy
10. Role of renin-angiotensin system in chronic renal hypertensive rats
11. Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats
12. The multifactorial role of catecholamines in hypertensive cardiac hypertrophy
13. Plasma concentration of angiotensin II and aldosterone during acute left ventricular failure in the dog
14. Tissue renin angiotensin systems: Focus on the heart
15. Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation
16. Protein measurements with the folin phenol reagent
17. L-(+)-Lactate
18. Adenosine-5′-tri-phosphate. UV-method with hexokinase and glucose-6-phosphate dehydrogenase
19. Creatine phosphate
20. Measurement and characterization of angiotensin peptides in plasma
21. 14C-noradrenaline by isolated rabbit hearts
22. Interaction of angiotensin converting enzyme inhibitors with the function of the sympathetic nervous system
23. Norepinephrine metabolism in hypertrophied rat hearts
24. Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure
25. Catecholamines and cardiac hyper-trophy
26. Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells
27. The mas oncogene encodes an angiotensin receptor
28. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains
29. Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat
30. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts
31. Prevention of coronary vasodilator reserve decrement in sponatneously hypertensive rats
32. Hypertensive vascular disease as a consequence of increased arterial pressure: quantitative study in rats with hydralazine-treated renal hypertension
33. Influence of nifedipine on degree of hypertrophy and transformation of the myocardium in experimental stenosis of the rat
34. Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect
35. Effect on hypertension, cardiac hypertrophy and atrial natriuretic peptides of treatment with nifedipine in SHR
36. Regression of myocardial and coronary vascular hypertrophy in hypertensive heart disease
37. Effect of angiotensin-converting enzyme inhibitor ramipril on noradrenaline-overflow from isolated working rat hearts subjected to myocardial ischemia and reperfusion
38. Ramiprilat attenuates local ischemia-induced release of noradrenaline via reduction in angiotensin II generation and bradykinin degradation
39. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors. A comparison of captopril, enalapril and HOE 498
40. Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats
41. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts
42. Influence of bradykinin on glucose uptake and metabolism in isolated cardiac myocytes and isolated perfused rat hearts
43. Converting enzyme inhibitor ramipril stimulates prostacyclin synthesis by isolated rat aorta: Evidence for a kinin-dependent mechanism
44. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
45. The effects of cyclic AMP and cyclic GMP on redox state and energy state in hypoxic rat atria
46. Energy metabolism and mechanical function in perfused hearts of syrian hamsters with dilated or hypertrophic cardiomyopathy
47. The creatine kinase system in normal and diseased human myocardium
48. Adenylate cyclase activity during development and reversal of cardiac hypertrophy